CVS Health Corp (CVS) Earnings: FY Adjusted EPS Forecast Raised Amid Strong Revenue Expectations

Cvs Health Corp on Smartkarma

Independent analysts on Smartkarma, like Baptista Research, are closely tracking CVS Health Corp’s performance. In one report titled “CVS Health: Can Its New PBM Strategy Finally Cut America’s Drug Costs?” by Baptista Research, insights show that CVS Health Corporation displayed a mix of success and challenges in the third quarter of 2025. The company exceeded expectations with an adjusted operating income of $3.5 billion and adjusted earnings per share (EPS) of $1.60, marking the third consecutive quarter of surpassing estimates. With an increased full-year adjusted EPS guidance to $6.55 to $6.65, CVS Health demonstrates confidence in their ongoing strategies.

Another report by Baptista Research, “CVS Health: Disrupting Retail Pharmacy With Game-Changing CostVantage Pricing Model!“, highlights the company’s impressive performance in the second quarter of 2025. The adjusted operating income reached $3.8 billion, alongside adjusted earnings per share (EPS) of $1.81. Notably, CVS Health has raised its full-year adjusted EPS guidance to a range of $6.30 to $6.40, a significant increase from the previous outlook of $6.00 to $6.20. These reports indicate a positive outlook and strategic moves by CVS Health in reshaping the retail pharmacy and healthcare landscape.

A look at Cvs Health Corp Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

CVS Health Corporation, an integrated pharmacy healthcare provider, seems well-positioned for the long term based on its Smartkarma Smart Scores. With strong scores in Value and Dividend, the company shows promise in terms of its financial health and potential for payouts to investors. Despite lower scores in Growth and Resilience, the company’s Momentum score suggests positive market sentiment and potential for future growth.

Supported by its extensive range of healthcare services and wide geographical presence across the U.S., the District of Columbia, and Puerto Rico, CVS Health Corporation appears to have a solid foundation for sustained success. Investors may find the company attractive for its combination of value, dividend prospects, and positive market momentum, despite some challenges in growth and resilience factors.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma